<--- Back to Details
First PageDocument Content
Chemistry / Biochemistry methods / Biophysics / Biochemistry / Glycosaminoglycans / Biology / Growth factors / Coagulation system / Heparin / Antithrombin / Isothermal titration calorimetry / Basic fibroblast growth factor
Date: 2011-09-28 10:31:22
Chemistry
Biochemistry methods
Biophysics
Biochemistry
Glycosaminoglycans
Biology
Growth factors
Coagulation system
Heparin
Antithrombin
Isothermal titration calorimetry
Basic fibroblast growth factor

Biomolecular Interaction and The Interactome.doc

Add to Reading List

Source URL: www-heparin.rpi.edu

Download Document from Source Website

File Size: 362,58 KB

Share Document on Facebook

Similar Documents

Blood / Medicine / Anatomy / Transfusion medicine / Hematology / Blood products / Coagulation system / Platelet / Blood transfusion / Hematocrit / Bleeding / Blood type

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

DocID: 1riKA - View Document

Cell biology / Biology / Blood / Programmed cell death / Apoptosis / Coagulation system / Cell signaling / Induced stem cells / Caspase / Platelet / Thrombopoiesis / Angiogenesis

Microsoft Wordfile00

DocID: 1r9dZ - View Document

Blood / Coagulation system / Anatomy / CSL Behring / Von Willebrand disease / Factor VIII / Coagulation / CSL Limited / Hereditary angioedema / Haemophilia / Factor IX / Factor VII

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

Medicine / Coagulation system / Thrombin / Antibody / Syringe / Surgical suture / Draft:Professor Dr. S Tsakas II

RECOTHROM, Thrombin topical (Recombinant) Package Insert

DocID: 1qv5K - View Document

Finance / Money / Economy / Transfusion medicine / Blood products / Corporate finance / Venture capital / Coagulation system / Platelet / Nesta / Bleeding / Seed money

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

DocID: 1qk7W - View Document